Abstract
The purpose of this study was to determine the impact of six PGHS-2 genetic variants on obesity development and microvascular dysfunction. The study included 305 Tunisian subjects (186 normal weights, 35 overweights and 84 obeses). PCR analyses were used for allelic discrimination between polymorphisms. Prostaglandin (PGE2, PGI2), leptin, and matrix metalloproteinase (MMP1, 2, 3, 9) levels were evaluated by ELISA. Fatty acid composition was performed by gas chromatography–mass spectrometry. Our results revealed that subjects carrying the PGHS-2 306CC (rs5277) and 8473CC (rs5275) genotypes present higher anthropometric values compared to wild-type genotypes (306GG, BMI (Kg/m2): 27.11 ± 0.58; WC (cm): 93.09 ± 1.58; 306CC, BMI: 33.83 ± 2.46; WC: 109.93 ± 5.41; 8473TT, BMI: 27.75 ± 0.68; WC: 93.96 ± 1.75; 8473CC, BMI: 33.72 ± 2.2; WC: 117.89 ± 2.94). A reduced microvascular reactivity and a higher PGE2 level were also found in individuals with the 306CC and 8473CC genotypes in comparison to 306GG and 8473TT carriers (306GG, Peak Ach-CVC (PU/mmHg): 0.46 ± 0.03; PGE2 (pg/ml): 7933.1 ± 702; 306CC, Peak Ach-CVC: 0.24 ± 0.01; PGE2: 13,380.3 ± 966.2; 8473TT, Peak Ach-CVC: 0.48 ± 0.05; PGE2: 7086.41 ± 700.31; 8473CC, Peak Ach-CVC: 0.23 ± 0.01; PGE2: 13,175.7 ± 1165.8). Fatty acid analysis showed a significant increase of palmitic acid (PA) (34.2 ± 2.09 vs. 16.82% ± 1.76, P < 0.001), stearic acid (SA) (25.76 ± 3.29 vs. 9.05% ± 2.53, P < 0.001), and linoleic acid (LA) (5.25 ± 1.18 vs. 0.5% ± 0.09, P < 0.001) levels in individuals carrying the PGHS-2 306CC genotype when compared to GG genotype individuals. Subjects with the 8473CC genotype showed also a significant increase of PA, SA ,and LA levels when compared to TT genotype carriers (PA: 38.02 ± 1.51 vs. 12.65% ± 1.54, P < 0.001; SA: 32.96 ± 1.87 vs. 1.38% ± 0.56, P < 0.001; LA: 26.84 ± 2.09 vs. 3.7% ± 1.54, P < 0.001). Logistic regression analysis revealed that PGHS-2 306CC and 8473CC variants are significantly associated with obesity status (OR 6.25, CI (1.8–21.6), P = 0.004; OR 3.01, CI (1.13–8.52), P = 0.03, respectively). Haplotypes containing the C306:T8473 (OR 2.91; P = 0.01) and G306:C8473 (OR 5.25; P = 0.002) combinations were associated with an enhanced risk for obesity development in the studied population. In conclusion, our results highlight that PGHS-2 306G/C and 8473T/C variants could be useful indicators of obesity development, inflammation, and microvascular dysfunction among Tunisians.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Al-Saleh W, Giannini SL, Jacobs N, Moutschen M, Doyen J, Boniver J, Delvenne P (1998) Correlation of T-helper secretory differentiation and types of antigen-presenting cells in squamous intraepithelial lesions of the uterine cervix. J Pathol 184(3):283–290. https://doi.org/10.1002/(SICI)1096-9896(199803)184:3%3c283::AID-PATH25%3e3.0.CO;2-K
Barati E, Ghazizadeh H, Sadabadi F, Kazemi E, Ferns GA, Avan A, Ghayour-Mobarhan M (2019) Association of the IL6 gene polymorphism with component features of metabolic syndrome in obese subjects. Biochem Genet 57(5):695–708. https://doi.org/10.1007/s10528-019-09913-5
Barry EL, Sansbury LB, Grau MV, Ali IU, Tsang S, Munroe DJ, Ahnen DJ, Sandler RS, Saibil F, Gui J, Bresalier RS, McKeown-Eyssen GE, Burke C, Baron JA (2009) Cyclooxygenase-2 polymorphisms, aspirin treatment, and risk for colorectal adenoma recurrence-data from a randomized clinical trial. Cancer Epidemiol Biomark Prev 18(10):2726–2733. https://doi.org/10.1158/1055-9965.EPI-09-0363
Ben Nasr H, Chahed K, Bouaouina N, Chouchane L (2009) PTGS2 (COX-2) -765 G>C functional promoter polymorphism and its association with risk and lymph node metastasis in nasopharyngeal carcinoma. Mol Biol Rep 36(1):193–200. https://doi.org/10.1007/s11033-007-9166-3
Boumiza S, Bchir S, Ben Nasr H, Abbassi A, Jacob MP, Norel X, Tabka Z, Chahed K (2017) Role of MMP-1 (-519A/G, -1607 1G/2G), MMP-3 (Lys45Glu), MMP-7 (-181A/G), and MMP-12 (-82A/G) variants and plasma MMP levels on obesity-related phenotypes and microvascular reactivity in a Tunisian population. Dis Mark 2017:6198526. https://doi.org/10.1155/2017/6198526
Chan IHS, Tang NLS, Leung TF, Ma SL, Zhang YP, Wong GWK, Wong CK, Lam CWK (2007) Association of prostaglandin-endoperoxide synthase 2 gene polymorphisms with asthma and atopy in Chinese children. Allergy 62(7):802–809. https://doi.org/10.1111/j.1398-9995.2007.01400.x
Chan PC, Hsiao FC, Chang HM, Wabitsch M, Hsieh PS (2016) Importance of adipocyte cyclooxygenase-2 and prostaglandin E2-prostaglandin E receptor 3 signaling in the development of obesity-induced adipose tissue inflammation and insulin resistance. FASEB J 30(6):2282–2297. https://doi.org/10.1096/fj.201500127
Chan PC, Liao MT, Hsieh PS (2019) The dualistic effect of COX-2-mediated signaling in obesity and insulin resistance. Int J Mol Sci 20(13):3115. https://doi.org/10.3390/ijms20133115
Chen R, Davydov EV, Sirota M, Butte AJ (2010) Non-synonymous and synonymous coding SNPs show similar likelihood and effect size of human disease association. PLoS ONE 5(10):e13574. https://doi.org/10.1371/journal.pone.0013574
Cipollone F, Patrono C (2002) Cyclooxygenase-2 polymorphism: putting a brake on the inflammatory response to vascular injury? Arterioscler Thromb Vasc Biol 22(10):1516–1518. https://doi.org/10.1161/01.atv.0000035402.68085.a0
Cipollone F, Fazia M, Iezzi A, Pini B, Cuccurullo C, Zucchelli M, de Cesare D, Ucchino S, Spigonardo F, De Luca M, Muraro R, Bei R, Bucci M, Cuccurullo F, Mezzetti A (2004) Blockade of the angiotensin II Type 1 receptor stabilizes atherosclerotic plaques in humans by inhibiting prostaglandin E2-dependent matrix metalloproteinase activity. Circulation 109(12):1482–1488. https://doi.org/10.1161/01.CIR.0000121735.52471.AC
Cipollone F, Toniato E, Martinotti S, Fazia M, Iezzi A, Cuccurullo C, Pini B, Ursi S, Vitullo G, Averna M, Arca M, Montali A, Campagna F, Ucchino S, Spigonardo F, Taddei S, Virdis A, Ciabattoni G, Notarbartolo A, Cuccurullo F, Mezzetti A, Identification of New Elements of Plaque Stability (INES) Study Group (2004a) A polymorphism in the cyclooxygenase 2 gene as an inherited protective factor against myocardial infarction and stroke. JAMA 291(18):2221–2228. https://doi.org/10.1001/jama.291.18.2221
Cohen-Eliav M, Golan-Gerstl R, Siegfried Z, Andersen CL, Thorsen K, Ørntoft TF, Mu D, Karni R (2013) The splicing factor SRSF6 is amplified and is an oncoprotein in lung and colon cancers. J Pathol 229(4):630–639. https://doi.org/10.1002/path.4129
Cox DG, Buring J, Hankinson SE, Hunter DJ (2007) A Polymorphism in the 3’ untranslated region of the gene encoding prostaglandin endoperoxide synthase 2 Is not associated with an increase in breast cancer risk: a nested case-control study. Breast Cancer Res 9(1):R3. https://doi.org/10.1186/bcr1635
Dimassi S, Chahed K, Boumiza S, Canault M, Tabka Z, Laurant P, Riva C (2016) Role of eNOS- and NOX-containing microparticles in endothelial dysfunction in patients with obesity. Obesity (Silver Spring) 24(6):1305–1312. https://doi.org/10.1002/oby.21508
Faul F, Erdfelder E, Buchner A, Lang A (2009) Statistical power analyses using G*Power 3.1: tests for correlation and regression analyses. Behav Res Methods 41(4):1149–1160. https://doi.org/10.3758/BRM.41.4.1149
Fawzy MS, Aly NMM, Shalaby SM, El-Sawy WH, Abdul-Maksoud RS (2013) Cyclooxygenase-2 169C>G and 8473T>C gene polymorphisms and prostaglandin E2 level in breast cancer: a case-control study. Gene 527(2):601–605. https://doi.org/10.1016/j.gene.2013.06.007
Fawzy MS, Elfayoumi AR, Mohamed RH, Abdel Fatah IR, Saadawy SF (2016) Cyclooxygenase 2 (rs2745557) polymorphism and the susceptibility to benign prostate hyperplasia and prostate cancer in Egyptians. Biochem Genet 54(3):326–336. https://doi.org/10.1007/s10528-016-9722-4
Fernando L, Alors-Perez E, Sarmento-Cabral A, Castano JP, Luque RM, Gahete MD (2018) Obesity is associated with a dysregulation in the splicing machinery components at the hepatic level: influence of metformin. Endocr Abstr 56:GP157. https://doi.org/10.1530/endoabs.56.GP157
Freitas-Alves DR, Vieira-Monteiro HA, Piranda DN, Sobral-Leite M, da Silva TSL, Bergmann A, Valença SS, Perini JA, Vianna-Jorge R (2018) PTGS2 polymorphism rs689466 favors breast cancer recurrence in obese patients. Endocr Relat Cancer 25(3):351–365. https://doi.org/10.1530/ERC-17-0374
Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18(6):499–502
Guerfali M, Ayadi I, Mohamed N, Ayadi W, Belghith H, Bronze MR, Ribeiro MHL, Gargouri A (2019) Triacylglycerols accumulation and glycolipids secretion by the oleaginous yeast Rhodotorulababjevae Y-SL7: structural identification and biotechnological applications. Bioresour Technol 273:326–334. https://doi.org/10.1016/j.biortech.2018.11.036
Guo S, Li X, Gao M, Kong H, Li Y, Gu M, Dong X, Niu W (2012) Synergistic association of PTGS2 and CYP2E1 genetic polymorphisms with lung cancer risk in northeastern Chinese. PLoS ONE 7(6):e39814. https://doi.org/10.1371/journal.pone.0039814
He J, Zhang Q, Ren Z, Li Y, Li X, Zhou W, Zhang H, Meng W, Yan J, He W (2012) Cyclooxygenase-2 -765 G/C polymorphisms and susceptibility to hepatitis B-related liver cancer in Han Chinese population. Mol Biol Rep 39(4):4163–4168. https://doi.org/10.1007/s11033-011-1199-y
Hellmann J, Zhang MJ, Tang Y, Rane M, Bhatnagar A, Spite M (2013) Increased saturated fatty acids in obesity alter resolution of inflammation in part by stimulating prostaglandin production. J Immunol 191(3):1383–1392. https://doi.org/10.4049/jimmunol.1203369
Hubáček JA, Pelikánová T, Lánská V, Komers R (2011) A polymorphism in the cyclooxygenase 2 gene in type 1 diabetic patients with nephropathy. Physiol Res 60:377–380. https://doi.org/10.33549/physiolres.932016
Juan-Mateu J, Alvelos MI, Turatsinze JV, Villate O, Lizarraga-Mollinedo E, Grieco FA, Marroquí L, Bugliani M, Marchetti P, Eizirik DL (2018) SRp55 regulates a splicing network that controls human pancreatic β-cell function and survival. Diabetes 67:423–436. https://doi.org/10.2337/db17-0736
Kim IJ, Kim SH, Cha DH, Lim SW, Moon JY, Kim JO, Ryu CS, Park HS, Sung JH, Kim NK (2019) Association of COX2 -765G>C promoter polymorphism and coronary artery disease in Korean population. Genes Genom 41(9):1055–1062. https://doi.org/10.1007/s13258-019-00835-5
Lee YS, Kim H, Wu TX, Wang XM, Dionne RA (2006) Genetically mediated interindividual variation in analgesic responses to cyclooxygenase inhibitory drugs. Clin Pharmacol Ther 79(5):407–418. https://doi.org/10.1016/j.clpt.2006.01.013
Lee TS, Jeon YT, Kim JW, Park NH, Kang SB, Lee HP, Song YS (2007) Lack of association of the cyclooxygenase-2 and inducible nitric oxide synthase gene polymorphism with risk of cervical cancer in Korean population. Ann NY Acad Sci 1095:134–142. https://doi.org/10.1196/annals.1397.017
Li Q, Liu L, Liu Y, Zhou H, Yang Z, Yuan K, Min W (2014) Five COX-2 gene polymorphisms and risk of breast cancer: an updated meta-analysis based on 19 case-control studies. Med Oncol 32(1):397. https://doi.org/10.1007/s12032-014-0397-6
Liu H, Xu Z, Sun C, Gu D, Teng X, Zhao Y, Zheng Z (2017) A Variant in COX-2 gene is associated with left main coronary artery disease and clinical outcomes of coronary artery bypass grafting. Biomed Res Int 2017:2924731. https://doi.org/10.1155/2017/2924731
Lu X, Chen F, Liu X, Yuan D, Zi Y, He X, He R (2015) Detection and clinical significance of COX-2 gene SNPs in gastric cancer. Cell Biochem Biophys 72(3):657–660. https://doi.org/10.1007/s12013-014-0465-8
Luo MX, Long BB, Li F, Zhang C, Pan MT, Huang YQ, Chen B (2018) Roles of cyclooxygenase-2 gene -765G > C (rs20417) and -1195G > A (rs689466) polymorphisms in gastric cancer: a systematic review and meta-analysis. Gene 685:125–135. https://doi.org/10.1016/j.gene.2018.10.077
Maguire J, Thakkinstian A, Levi C, Lincz L, Bisset L, Sturm J, Scott R, Whyte S, Attia J (2011) Impact of COX-2 rs5275 and rs20417 and GP IIIa rs5918 polymorphisms on 90-day ischemic stroke functional outcome: a novel finding. J Stroke Cerebrovasc Dis 20(2):134–144. https://doi.org/10.1016/j.jstrokecerebrovasdis.2009.10.011
Mamounis KJ, Yasrebi A, Roepke TA (2016) Linoleic acid causes greater weight gain than saturated fat without hypothalamic inflammation in the male mouse. J Nutr Biochem 40:122–131. https://doi.org/10.1016/j.jnutbio.2016.10.016
Markkula A, Simonsson M, Rosendahl AH, Gaber A, Ingvar C, Rose C, Jernström H (2014) Impact of COX2 genotype, ER status and body constitution on risk of early events in different treatment groups of breast cancer patients. Int J Cancer 135(8):1898–1910. https://doi.org/10.1002/ijc.28831
McGettigan P, Lincz LF, Attia J, McElduff P, Bissett L, Peel R, Stokes B, Hancock S, Henderson K, Seldon M, Henry D (2011) The risk of coronary thrombosis with cyclo-oxygenase-2 inhibitors does not vary with polymorphisms in two regions of the cyclo-oxygenase-2 gene. Br J Clin Pharmacol 72(4):707–714
Miâdi-Messaoud H, Chouchane A, Abderrazek E, Debbabi H, Zaouali-Ajina M, Tabka Z, Ben-Jebria A (2010) Obesity-induced impairment of endothelium-dependent vasodilation in Tunisian women. Int J Obes (Lond) 34(2):273–279. https://doi.org/10.1038/ijo.2009.231
Moatter T, Aban M, Iqbal W, Pervez S (2014) Cyclooxygenase-2 polymorphisms and breast cancer associated risk in Pakistani patients. Pathol Oncol Res 21(1):97–101. https://doi.org/10.1007/s12253-014-9792-8
Moore AE, Young LE, Dixon DA (2012) A common single-nucleotide polymorphism in cyclooxygenase-2 disrupts microRNA-mediated regulation. Oncogene 31(12):1592–1598. https://doi.org/10.1038/onc.2011.349
Mosallaei M, Simonian M, Ahangari F, Miraghajani M, Mortazavi D, Salehi AR, Salehi R (2018) Single nucleotide polymorphism rs4648298 in miRNAs hsa-miR21 and hsa-miR590 binding site of COX gene is a strong colorectal cancer determinant. J Gastrointest Oncol 9(3):448 457. https://doi.org/10.21037/jgo.2017.11.01
Mouradian M, Kikawa KD, Johnson ED, Beck KL, Pardini RS (2014) Key roles for GRB2-associated-binding protein 1, phosphatidylinositol-3-kinase, cyclooxygenase 2, prostaglandin E2 and transforming growth factor alpha in linoleic acid-induced upregulation of lung and breast cancer cell growth. Prostaglandins Leukot Essent Fatty Acids 90(4):105–115. https://doi.org/10.1016/j.plefa.2013.12.001
Muñoz M, Sánchez A, Pilar Martínez M, Benedito S, López-Oliva ME, García-Sacristán A, Hernández M, Prieto D (2015) COX-2 is involved in vascular oxidative stress and endothelial dysfunction of renal interlobar arteries from obese Zucker rats. Free Radic Biol Med 84:77–90. https://doi.org/10.1016/j.freeradbiomed.2015.03.024
Nasr HB, Dimassi S, M’hadhbi R, Debbabi H, Kortas M, Tabka Z, Chahed K (2016) Functional G894T (rs1799983) polymorphism and intron-4 VNTR variant of nitric oxide synthase (NOS3) gene are susceptibility biomarkers of obesity among Tunisians. Obes Res Clin Pract 10(4):465–475. https://doi.org/10.1016/j.orcp.2015.04.008
Ozbayer C, Kebapci MN, Degirmenci I, Yagci E, Gunes HV, Kurt H (2018) Genetic variant in the 3’-untranslated region of the COX2 gene is associated with type 2 diabetes: a hospital-based case-control study. Prostaglandins Leukot Essent Fatty Acids 137:39–42. https://doi.org/10.1016/j.plefa.2018.07.012
Ozen G, Boumiza S, Deschildre C, Topal G, Longrois D, Jakobsson PJ, Michel JB, Jacob MP, Chahed K, Norel X (2019) Inflammation increases MMP levels via PGE2 in human vascular wall and plasma of obese women. Int J Obes (Lond) 43(9):1724–1734. https://doi.org/10.1038/s41366-018-0235-6
Papafili A, Hill MR, Brull DJ, McAnulty RJ, Marshall RP, Humphries SE, Laurent GJ (2002) Common promoter variant in cyclooxygenase-2 represses gene expression: evidence of role in acute-phase inflammatory response. Arterioscler Thromb Vasc Biol 22(10):1631–1636. https://doi.org/10.1161/01.atv.0000030340.80207.c5
Prakash G, Umar M, Ajay S, Bali D, Upadhyay R, Gupta KK, Dixit J, Mittal B (2015) COX-2 gene polymorphismsand risk of chronic periodontitis: a case-control study and meta-analysis. Oral Dis 21(1):38–45. https://doi.org/10.1111/odi.12203
Rajasekaran S, Kanna RM, Senthil N, Raveendran M, Ranjani V, Cheung KMC, Chan D, Kao PYP, Yee A, Shetty AP (2014) Genetic susceptibility of lumbar degenerative disc disease in young Indian adults. Eur Spine J 24(9):1969–1975. https://doi.org/10.1007/s00586-014-3687-y
Rudock ME, Liu Y, Ziegler JT, Allen SG, Lehtinen AB, Freedman BI, Carr JJ, Langefeld CD, Bowden DW (2009) Association of polymorphisms in cyclooxygenase (COX)-2 with coronary and carotid calcium in the diabetes heart study. Atherosclerosis 203(2):459–465. https://doi.org/10.1016/j.atherosclerosis.2008.07.018
Sanak M, Szczeklik W, Szczeklik A (2005) Association of COX-2 gene haplotypes with prostaglandins production in bronchial asthma. J Allergy Clin Immunol 116(1):221–223. https://doi.org/10.1016/j.jaci.2005.03.010
Szczeklik W, Sanak M, Szczeklik A (2004) Functional effects and gender association of COX-2 gene polymorphism G-765C in bronchial asthma. J Allergy Clin Immunol 114(2):248–253. https://doi.org/10.1016/j.jaci.2004.05.030
Upadhyay R, Jain M, Kumar S, Ghoshal UC, Mittal B (2009) Functional polymorphisms of cyclooxygenase-2 (COX-2) gene and risk for esophageal squmaous cell carcinoma. Mutat Res 663(1–2):52–59. https://doi.org/10.1016/j.mrfmmm.2009.01.007
Wong CM, Xu L, Yau MYC (2018) Alternative mRNA splicing in the pathogenesis of obesity. Int J Mol Sci 19(2):632. https://doi.org/10.3390/ijms19020632
Xaubet A, Fu WJ, Li M, Serrano-Mollar A, Ancochea J, Molina-Molina M, Rodriguez-Becerra E, Morell F, Rodríguez-Arias JM, Pereda J, Casanova A, Molins L, Picado C (2010) A haplotype of cyclooxygenase-2 gene is associated with idiopathic pulmonary fibrosis. Sarcoidosis Vasc Diffus Lung Dis 27(2):121–130
Xing LL, Wang ZN, Jiang L, Zhang Y, Xu YY, Li J, Luo Y, Zhang X (2008) Cyclooxygenase 2 polymorphism and colorectal cancer: -765G>C variant modifies risk associated with smoking and body mass index. World J Gastroenterol 14(11):1785–1789. https://doi.org/10.3748/wjg.14.1785
Yi X, Lin J, Luo H, Wang C, Liu Y (2017) Genetic variants of PTGS2, TXA2R and TXAS1 are associated with carotid plaque vulnerability, platelet activation and TXA2 levels in ischemic stroke patients. PLoS ONE 12(7):e0180704. https://doi.org/10.1371/journal.pone.0180704
Yu KD, Chen AX, Yang C, Qiu LX, Fan L, Xu WH, Shao ZM (2010) Current evidence on the relationship between polymorphisms in the COX-2 gene and breast cancer risk: a meta-analysis. Breast Cancer Res Treat 122(1):251–257. https://doi.org/10.1007/s10549-009-0688-3
Zeng J, Zhang Y, Hao J, Sun Y, Liu S, Bernlohr DA, Sauter ER, Cleary MP, Suttles J, Li B (2018) Stearic acid induces CD11c expression in Proinflammatory macrophages via epidermal fatty acid binding protein. J Immunol 200(10):3407–3419. https://doi.org/10.4049/jimmunol.1701416
Zhang H, Xu Y, Zhang Z, Liu R, Ma B (2012) Association between COX-2 rs2745557 polymorphism and prostate cancer risk: a systematic review and meta-analysis. BMC Immunol 13:14. https://doi.org/10.1186/1471-2172-13-14
Zhao L, Fang J, Zhou M, Zhou J, Yu L, Chen N, He L (2019) Interaction between COX-1 and COX-2 increases susceptibility to ischemic stroke in a Chinese population. BMC Neurol 19(1):291. https://doi.org/10.1186/s12883-019-1505-1
Zhou H, Urso CJ, Jadeja V (2020) Saturated fatty acids in obesity-associated inflammation. J Inflamm Res 13:1–14. https://doi.org/10.2147/JIR.S229691
Acknowledgements
This work was supported by the Ministry of Higher Education and Scientific Research and by the Ministry of Public Health of the Tunisian Government. The authors wish to thank all the patients and controls who participated in this study. The authors gratefully acknowledge the assistance and effort of Ines Ayadi and Wided Khamlaoui during GS-MS analysis.
Author information
Authors and Affiliations
Contributions
AT collected clinical samples, designed the study, analyzed and interpreted data, and revised the manuscript. SB, HbN and SB collected clinical samples and revised the manuscript. XN performed ELISA experiments. ZT collected clinical samples, recorded the clinical characteristics of participants, and revised the manuscript. KC contributed to experimental design, analyzed and interpreted data, performed literature review, and wrote up the main structure of the manuscript. All authors read and approved the submitted manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors AT, SB, HbN, SB, XN, ZT, and KC have no conflicts of interest that are directly relevant to the content of this article.
Ethical Approval and Informed Consent
The study was approved by the local ethical committee of Farhat Hachad Hospital (Sousse, Tunisia, approval number: 08-2011).
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Touir, A., Boumiza, S., Nasr, H.b. et al. Prostaglandin Endoperoxide H Synthase-2 (PGHS-2) Variants and Risk of Obesity and Microvascular Dysfunction Among Tunisians: Relevance of rs5277 (306G/C) and rs5275 (8473T/C) Genetic Markers. Biochem Genet 59, 1457–1486 (2021). https://doi.org/10.1007/s10528-021-10071-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10528-021-10071-w